Latest California Healthline Stories
Listen: Why Childbirth Is So Dangerous for Many Young Teens
KHN senior correspondent Sarah Varney talks with NPR’s “Weekend Edition Sunday” about how the abortion bans proliferating in many U.S. states will affect teenage birth rates and the physical risks that trend poses for girls.
Comienzan a estar disponibles audífonos de venta libre desde $199
Los audífonos de venta libre cuestan menos en parte porque no incluyen los servicios de un experto para una evaluación auditiva, ajuste y afinación del dispositivo. En cambio, los nuevos dispositivos deben ser configurados por los propios consumidores.
Weight Loss Gadgets Help Consumers Achieve Diet Goals — But It Still Won’t Be Easy
You may have seen the ads that promise weight loss and better health — phone apps, rings, and other devices — by giving you data on how your body reacts to food, exercise, and sleep. Is this information enough to help consumers achieve their goals?
Lawsuit by KHN Prompts Government to Release Medicare Advantage Audits
The lawsuit was filed three years ago to learn about vast overcharges by the popular health plans that are detailed in audits the government refused to release to the public.
Will Covid Spike Again This Fall? 6 Tips to Help You Stay Safe
Recent research suggests that the covid virus is mutating to better dodge people’s immune defenses. It could soon evade monoclonal antibodies used to treat covid. KHN examines what public health officials believe is on the horizon and how best to fight the disease.
KHN’s ‘What the Health?’: Finally Fixing the ‘Family Glitch’
The Biden administration has decided to try to fix the so-called “family glitch” in the Affordable Care Act without an act of Congress. The provision has prevented workers’ families from getting subsidized coverage if an employer offer is unaffordable. Meanwhile, Medicare’s open enrollment period begins Oct. 15, and private Medicare Advantage plans are poised to cover more than half of Medicare’s 65 million enrollees. Margot Sanger-Katz of The New York Times, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these topics and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read.
La nueva generación de medicamentos para la pérdida de peso es prometedora, pero tiene un precio
Algunos pacientes, según los especialistas en medicina de la obesidad, experimentan una disminución de la presión arterial, un mejor control de la diabetes, menos dolor en las articulaciones y un mejor sueño gracias a estos nuevos tratamientos.
New Generation of Weight Loss Medications Offer Promise — But at a Price
People now have at their disposal more medicines that are effective at reducing weight, but none can counter obesity alone. One big problem: Insurance coverage remains spotty, and the costly drugs may be needed long term.
‘An Arm and a Leg’: Checking Up on California’s DIY Insulin Project
California put up $100 million to produce its own insulin. How did this plan come to be, and what might stand in the state’s way?
Baby, That Bill Is High: Private Equity ‘Gambit’ Squeezes Excessive ER Charges From Routine Births
Hospitals, boosted by private equity-backed staffing companies, have embraced a new idea: the obstetrics emergency department. Often, it is just a triage room in the labor-and-delivery area, but it bills like the main emergency department.